Arango PC

Language: Spanish
References: 10
Page: 80-86
PDF size: 78.22 Kb.

ABSTRACT

The osteoarthritis is the most common articular disease. Motivated for the bone and joint decade, many efforts have been done trying to clarify the etiology and to improve the treatments choices. The OA, has been considered as a public worldwide problem. The possible causes of OA, are genetics, life style, constitutional factors, limbs misalignments metabolic diseases, increase of longevity among others. There is a common factor in OA, and is the lost of viscoelasticity of synovial fluid, in more than 50%. The treatment options include. Changes in dayliving activities, weight lost, analgesics, intraarticular corticosteroids, hyaluronic acid, stem cells, growth factors and many surgical procedures such as; osteotomies, arthroscopic debridement, ostheocondral auto or allografts, chondrocyte transplantation and joint replacements. The treatment with intraarticular hyaluronic acid (Viscosupplementation), has demonstrated to enhance the articular homeostasis, increasing the viscoelasticity of synovial fluid and promoting the production of endogenous hyaluronic acid. Thus improving pain and function, with minimal side effects.

REFERENCES

1. Langworthy MJ, Saad A, Langworthy NM. Conservative treatment modalities and outcomes for osteoarthritis: the concomitant pyramid of treatment. Phys Sportsmed 2010; 2(38): 133-145.

2. Doherty P. The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage 2009; 17(10): 1255-1262.

3. Divine JG, Zazulak B, Newett TE. Viscosupplementation for knee osteoarthritis: a systematic review. Clinical Orthopaedics & Related Research 2007; 455: 113-122.

4. Bagga H, Burkhardt D, Sambrook P. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Reumatol 2006; 33(5): 946-950.

5. Blaine T, Moskowitz R, Udell J, Skynar M, Levin R, Friedlander J, Daley M, Altman R. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 2008; 90: 970-979.

6. Eckstein F, Cicuttini F, Raynauld JP. Magnetic resonance imagin (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis and Cartilage 2006; 14: A46-A75.

7. Rolf CG, Engstrom B, Ohrvik J, Valentin A, Lilja B, Levinec DW. A comparative study of the efficacy and safety of hyaluronas viscosupplements and placebo in patients symptomatic and arthroscopic verified cartilage pathology. J Clin Research 2005; 8: 15-32.

8. Zietz PM, Selesnick H. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis. Arthroscopy 2008; 24(4): 416-422.

9. Waddell DD, Bert JM. The use of hyaluronan after arthroscopic surgery of the knee. Arthroscopy 2010; 26(1): 105-111.

10. Carborn D, Rush J, Lanzar W, Parentinolo D. A randomized, single –blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the Knee. J Rheumatol 2004; 31(2): 333-343.